Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Sudarshan Pharma Industries Limited (NSE: SUDARSHAN), ISIN INE00TV01023 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SUDARSHAN last traded at ₹33.89 (+1.68%), with a 52-week range of ₹31.01 to ₹39.30 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 57.81%, FIIs 21.94%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 64/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.